Dana Schonberg1, Lin-Fan Wang2, Ariana H Bennett3, Marji Gold2, Emily Jackson4. 1. Montefiore Medical Center/Albert Einstein College of Medicine, Bronx NY. Electronic address: dschonbe@montefiore.org. 2. Montefiore Medical Center/Albert Einstein College of Medicine, Bronx NY. 3. Albert Einstein College of Medicine, Bronx NY. 4. Planned Parenthood of Orange and San Bernardino Counties, Orange, CA.
Abstract
OBJECTIVE: We sought to evaluate the accuracy of assessing gestational age (GA) prior to first trimester medication abortion using last menstrual period (LMP) compared to ultrasound (U/S). STUDY DESIGN: We searched Medline, Embase and Cochrane databases through October 2013 for peer-reviewed articles comparing LMP to U/S for GA dating in abortion care. Two teams of investigators independently evaluated data using standard abstraction forms. The US Preventive Services Task Force and Quality Assessment of Diagnostic Accuracy Studies guidelines were used to assess quality. RESULTS: Of 318 articles identified, 5 met inclusion criteria. Three studies reported that 2.5-11.8% of women were eligible for medication abortion by LMP and ineligible by U/S. The number of women who underestimated GA using LMP compared to U/S ranged from 1.8 to 14.8%, with lower rates found when the sample was limited to a GA <63 days. Most women (90.5-99.1%) knew their LMP, 70.8-90.5% with certainty. CONCLUSION: Our results support that LMP can be used to assess GA prior to medication abortion at GA <63 days. Further research looking at patient outcomes and identifying women eligible for medication abortion by LMP but ineligible by U/S is needed to confirm the safety and effectiveness of providing medication abortion using LMP alone to determine GA.
OBJECTIVE: We sought to evaluate the accuracy of assessing gestational age (GA) prior to first trimester medication abortion using last menstrual period (LMP) compared to ultrasound (U/S). STUDY DESIGN: We searched Medline, Embase and Cochrane databases through October 2013 for peer-reviewed articles comparing LMP to U/S for GA dating in abortion care. Two teams of investigators independently evaluated data using standard abstraction forms. The US Preventive Services Task Force and Quality Assessment of Diagnostic Accuracy Studies guidelines were used to assess quality. RESULTS: Of 318 articles identified, 5 met inclusion criteria. Three studies reported that 2.5-11.8% of women were eligible for medication abortion by LMP and ineligible by U/S. The number of women who underestimated GA using LMP compared to U/S ranged from 1.8 to 14.8%, with lower rates found when the sample was limited to a GA <63 days. Most women (90.5-99.1%) knew their LMP, 70.8-90.5% with certainty. CONCLUSION: Our results support that LMP can be used to assess GA prior to medication abortion at GA <63 days. Further research looking at patient outcomes and identifying women eligible for medication abortion by LMP but ineligible by U/S is needed to confirm the safety and effectiveness of providing medication abortion using LMP alone to determine GA.
Authors: Edith R Guilbert; Althea S Hayden; Heidi E Jones; Katharine O'Connell White; E Steven Lichtenberg; Maureen Paul; Wendy V Norman Journal: Can Fam Physician Date: 2016-04 Impact factor: 3.275
Authors: Wenwen Jiang; Keshet Ronen; Lusi Osborn; Alison L Drake; Jennifer A Unger; Daniel Matemo; Daniel A Enquobahrie; John Kinuthia; Grace John-Stewart Journal: AIDS Date: 2022-03-04 Impact factor: 4.632